2050-20-6Relevant articles and documents
Novel Myocyte Enhancer Factor 2 (MEF2) modulators
-
Paragraph 0105-0107, (2019/08/20)
The present disclosure provides novel compounds capable of functioning as Myoctye Enhancer Factor 2 (MEF2) modulators, as well as compositions, pharmaceutical formulations, methods of synthesis and kits. Also provided are methods of treating a condition regulatable by MEF2 and/or MEF2 cofactors using the compounds, compositions, pharmaceutical formulations, and kits provided herein.
NOVEL TRANSCRIPTION FACTOR MODULATORS
-
Paragraph 0178; 0181; 0182, (2014/09/29)
The present disclosure provides novel compounds capable of functioning as transcription factor modulators, as well as compositions, pharmaceutical formulations, and kits. Also provided are methods of treating a condition regulatable by a transcription factor and/or cofactor using the compounds, compositions, pharmaceutical formulations, and kits provided herein.
Highly chemoselective, oxyvanadium-catalysed cleavage of α-hydroxy ketones
Kirihara, Masayuki,Takizawa, Shinobu,Momose, Takefumi
, p. 7 - 8 (2007/10/03)
α-Hydroxy ketones (α-ketols) can be cleaved chemoselectively with a catalytic amount of dichloroethoxyoxyvanadium under an oxygen atmosphere.